首页 产品目录 分子砌块 按应用领域 分子与化学生命科学 生化试剂 药物研究试剂 2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-羟基-6a,8a,10-三甲基-4-氧代-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-十二氢-8bH-萘并[2',1':4,5]茚并[1,2-d]噁唑-8b-基)-2-氧代乙基乙酸酯

2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-羟基-6a,8a,10-三甲基-4-氧代-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-十二氢-8bH-萘并[2',1':4,5]茚并[1,2-d]噁唑-8b-基)-2-氧代乙基乙酸酯

2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-6a,8a,10-trimethyl-4-oxo-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d]oxazol-8b-yl)-2-oxoethyl acetate

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

14484-47-0

中文名称

2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-羟基-6a,8a,10-三甲基-4-氧代-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-十二氢-8bH-萘并[2',1':4,5]茚并[1,2-d]噁唑-8b-基)-2-氧代乙基乙酸酯

英文名称

2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-6a,8a,10-trimethyl-4-oxo-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d]oxazol-8b-yl)-2-oxoethyl acetate

别名

LS-13240 | DEFLAZACORT (MART.) | Deflazacort, United States Pharmacopeia (USP) Reference Standard | T70289 | Deflazacort (USAN/INN) | DTXSID9020378 | InChI=1/C3H5ClO/c1-2-3(4)5/h2H2,1H | Oxazacort | 2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-6a,8a,1

标准英文名

2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-6a,8a,10-trimethyl-4-oxo-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d]oxazol-8b-yl)-2-oxoethyl acetate

MDL No.

MFCD00866106

分子式

C25H31NO6

分子量

441.52

精确分子量

441.22

SMILES

CC(=O)OCC(=O)[C@@]12N=C(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C

标准SMILES

CC(=O)OCC(=O)[C@@]12N=C(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]21C

用途

Deflazacort is a third-generation glucocorticoid with anti-inflammatory, anti-allergic, and gluconeogenesis-enhancing effects. It is used for primary and secondary adrenal insufficiency, rheumatic diseases, collagen diseases, dermatological conditions, allergic and hypersensitivity disorders, ophthalmic diseases, fulminant and disseminated tuberculosis (in combination with antitubercular drugs), hematologic disorders, ulcerative colitis, idiopathic nephrotic syndrome, and hematologic malignancies.

InChIKey

FBHSPRKOSMHSIF-GRMWVWQJSA-N

安全信息

SureRoute逆合成路线

1.  14484-47-0 逆合成路线 1

—
—
ACMCZI252
14484-47-0
来源: SureRoute

2.  14484-47-0 逆合成路线 2

—
—
ACMCZI252
14484-47-0
来源: SureRoute

3.  14484-47-0 逆合成路线 3

ACCZIU451
563-67-7
—
—
ACMCZI252
14484-47-0
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手